The mission of this Program is to prepare a cadre of outstanding cancer epidemiologists through rigorous academic training in research methodology and the epidemiology and biology of cancer, and/or mentored research. Those in the Molecular & Genetic Epidemiology Sub-program receive additional training in the application of molecular genetic techniques to epidemiologic research. A distinguished faculty provides substantial opportunity for research experience. There are three types of trainees: Doctoral Candidates in Epidemiology include both pre-doctoral candidates and those holding a prior doctoral degree (generally clinicians) who undertake 2-3 years of coursework in addition to research; Clinical Researchers include physicians with specialty training in cancer preparing for careers in clinical epidemiology who undertake a one year Master's degree program in methodology followed by a year of research; and Post-doctoral Fellows who hold a prior doctora! degree in Epidemiology or in Biology and undertake mentored research (and coursework if needed) in preparation for an academic career. Trainee positions are generally awarded for 2 or 3 years. The number of trainees requested include 3-4 pre-doctoral and 1-2 post-doctoral Doctoral Candidates; 2 Clinical Researchers; 2 Post-doctoral Fellows with an additional 4 pre-doctoral Doctoral Candidates and 3 Post-doctoral Fellows in the Sub-program for a total of 16 trainees. The Program is based in the Department of Epidemiology of the Harvard School of Public Health. A dedicated molecular epidemiology laboratory is available. This proposal continues a long history of excellence in training in cancer epidemiology at Harvard University.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009001-31
Application #
7109366
Study Section
Subcommittee G - Education (NCI)
Program Officer
Damico, Mark W
Project Start
1978-07-01
Project End
2009-06-30
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
31
Fiscal Year
2006
Total Cost
$745,969
Indirect Cost
Name
Harvard University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Busch, Evan L; Whitsel, Eric A; Kroenke, Candyce H et al. (2018) Social relationships, inflammation markers, and breast cancer incidence in the Women's Health Initiative. Breast 39:63-69
Taber, Jennifer M; Dickerman, Barbra A; Okhovat, Jean-Phillip et al. (2018) Skin cancer interventions across the cancer control continuum: Review of technology, environment, and theory. Prev Med 111:451-458
Geller, Alan C; Dickerman, Barbra A; Taber, Jennifer M et al. (2018) Skin cancer interventions across the cancer control continuum: A review of experimental evidence (1/1/2000-6/30/2015) and future research directions. Prev Med 111:442-450
Hirko, Kelly A; Chai, Boyang; Spiegelman, Donna et al. (2018) Erythrocyte membrane fatty acids and breast cancer risk: a prospective analysis in the nurses' health study II. Int J Cancer 142:1116-1129
Simon, Tracey G; King, Lindsay Y; Chong, Dawn Q et al. (2018) Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies. Hepatology 67:1797-1806
Graff, Rebecca E; Ahearn, Thomas U; Pettersson, Andreas et al. (2018) Height, Obesity, and the Risk of TMPRSS2:ERG-Defined Prostate Cancer. Cancer Epidemiol Biomarkers Prev 27:193-200
Sinnott, Jennifer A; Cai, Tianxi (2018) Pathway aggregation for survival prediction via multiple kernel learning. Stat Med 37:2501-2515
Hart, Jaime E; Bertrand, Kimberly A; DuPre, Natalie et al. (2018) Exposure to hazardous air pollutants and risk of incident breast cancer in the nurses' health study II. Environ Health 17:28
Busch, Evan L; Crous-Bou, Marta; Prescott, Jennifer et al. (2018) Adiponectin, Leptin, and Insulin-Pathway Receptors as Endometrial Cancer Subtyping Markers. Horm Cancer 9:33-39
Dickerman, Barbra A; Torfadottir, Johanna E; Valdimarsdottir, Unnur A et al. (2018) Midlife metabolic factors and prostate cancer risk in later life. Int J Cancer 142:1166-1173

Showing the most recent 10 out of 472 publications